Circassia, the Oxford (UK) based drug maker is aiming for a stock market listing valuing the company at more than £500m. The whole flotation hangs on their discovery of a treatment for cat allergies. Circassisia claims that their product Toleromune is effective at negating allergies caused by cats after a short immunotherapy course. This cure would apply to millions across the world who are cat sensitive including many cat owners and those who would like to be cat owners but daren't.
'I love you really'Source: Circassia web site; Daily Telegraph Feb 6th